Ellington Management Group’s Chemours CC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-59,300
Closed -$526K 96
2020
Q1
$526K Buy
+59,300
New +$855K 0.12% 240
2019
Q1
Sell
-19,842
Closed -$560K 569
2018
Q4
$560K Buy
+19,842
New +$628K 0.17% 146
2018
Q2
Sell
-68,100
Closed -$3.32M 547
2018
Q1
$3.32M Buy
+68,100
New +$3.4M 0.24% 28
2017
Q3
Sell
-7,700
Closed -$292K 654
2017
Q2
$292K Sell
7,700
-33,500
-81% -$1.32M 0.04% 405
2017
Q1
$1.59M Buy
+41,200
New +$1.24M 0.05% 26
2016
Q2
Sell
-14,700
Closed -$103K 295
2016
Q1
$103K Buy
14,700
+1,800
+14% +$9.04K 0.04% 467
2015
Q4
$69K Buy
+12,900
New +$82.4K 0.02% 552

Other funds holding CC

Ellington Management Group's CC Position: Q2 2020 in Review

Ellington Management Group sold out of Chemours (CC) in Q2 2020, closing a stake of 59,300 shares — an estimated $526K sold.

Ellington Management Group first reported a position in CC in Q4 2015 and held it in 7 quarters. The position peaked at $3.32M in Q1 2018. 396 funds tracked by Wall St. Rank hold CC as of Q2 2020.

  • Ellington Management Group reported no remaining Chemours position as of Q2 2020 after selling out during the quarter.
  • Ellington Management Group sold 59,300 Chemours shares in Q2 2020, an estimated $526K.
  • Ellington Management Group first reported a position in Chemours in Q4 2015 and held it in 7 quarters.
  • Ellington Management Group's Chemours position peaked at $3.32M in Q1 2018.
  • 396 funds tracked by Wall St. Rank held Chemours as of Q2 2020.

Based on Ellington Management Group's 13F filing for Q2 2020, filed 17 Aug 2020.